📊 Key Data
  • Stock Decline: USANA's stock has dropped over 32% in the past year.
  • Hiya Health Sales: $32 million in Q1 2026 with 186,000 active monthly subscribers.
  • Rise Wellness Growth: Net sales surged to $14 million in Q1 2026, an eightfold increase from the prior year.
🎯 Expert Consensus

Experts will likely conclude that USANA's strategic pivot toward omnichannel growth shows promising early results but faces significant challenges in sustaining momentum amid a declining core direct-selling business.

6 days ago
USANA's High-Stakes Pivot: Q2 Earnings to Reveal Omnichannel Future

USANA's High-Stakes Pivot: Q2 Earnings to Reveal Omnichannel Future

SALT LAKE CITY, UT – July 14, 2026 – USANA Health Sciences, Inc. (NYSE: USNA) is gearing up for a pivotal moment as it prepares to release its second-quarter 2026 financial results after the market closes on Tuesday, August 4. While earnings announcements are routine, this report is anything but. For investors and industry analysts, the upcoming figures represent a critical progress report on the company's ambitious transformation from a legacy direct-selling giant into a diversified, omnichannel health and wellness enterprise.

With its stock price having declined over 32% in the past year, the pressure is on for the Salt Lake City-based firm to demonstrate that its strategic acquisitions and channel diversification are not just theoretical but are translating into sustainable growth. The subsequent investor call on August 5 will be closely scrutinized for management's insights into the performance of its new brands and the health of its core business.

A Strategic Pivot to Omnichannel Growth

The central narrative for USANA is no longer solely about its traditional network of Brand Partners. The company is aggressively building a multi-pronged growth engine, a strategy brought into sharp focus by its recent acquisitions. The most significant of these was the December 2024 purchase of a 78.8% controlling stake in Hiya Health Products for $205 million. Hiya, a direct-to-consumer (DTC) provider of children's vitamins, operates on a popular subscription model, giving USANA immediate access to a new demographic and a recurring revenue stream.

The early results are promising. In the first quarter of 2026, Hiya generated $32 million in net sales with a robust base of 186,000 active monthly subscribers. The brand is also expanding its reach beyond its digital roots, launching in Canada and the United Kingdom and securing shelf space in major brick-and-mortar retailers like Target. This move showcases a synergistic strategy where USANA leverages its international expansion expertise to scale a nimble DTC brand.

Simultaneously, USANA's 100%-owned Rise Wellness subsidiary is making significant waves in the functional foods space. Comprising the Rise Bar and Protein Pop brands, Rise Wellness is capitalizing on the soaring consumer demand for clean-label, high-protein snacks. Its performance in the first quarter was explosive, with net sales hitting $14 million—an over eightfold increase from the prior year. This surge was largely fueled by the national launch of its Protein Pop Plus product in Costco. With new agreements in place with nine major U.S. retailers and a presence in 500 Walmart stores, Rise is rapidly becoming a formidable force in retail channels, a stark departure from USANA's direct-selling origins.

This diversification is a calculated response to evolving market dynamics. Management has noted that these omnichannel brands, which accounted for a mere 1% of consolidated net sales in 2024, grew to represent 16% in 2025. The company projects this figure will exceed 20% in fiscal 2026, signaling a fundamental shift in its business composition.

Reading the Financial Tea Leaves

Investors heading into the Q2 announcement will be benchmarking the results against a surprisingly strong first quarter and the company's own full-year guidance. In Q1 2026, USANA comfortably beat analyst expectations, reporting earnings per share (EPS) of $0.61 against a consensus of $0.44, on revenue of $250.22 million which surpassed estimates of $240.99 million. This performance was driven by sequential growth in its core China market and the powerful contributions from Hiya and Rise.

For the full fiscal year 2026, the health science firm has guided for consolidated net sales between $925 million and $1.0 billion, which would represent flat to 8% growth over the prior year. The crucial question for Q2 is whether the momentum from its omnichannel segments can continue to offset persistent challenges in its core direct-selling business, which saw an 8% decline in net sales in 2025.

Analysts are watching closely. While revenue forecasts have remained steady around $945 million for the year, EPS estimates have recently been revised upward from $1.11 to $1.29, suggesting a glimmer of optimism. The consensus price target hovers around $39.00. The upcoming report will either validate this cautious optimism or force a re-evaluation of the stock's potential, which some observers feel may be undervalued after its significant drop.

Navigating a Dynamic Health and Wellness Landscape

USANA's strategic pivot is not happening in a vacuum. It is a direct response to powerful, intersecting trends reshaping the entire health and wellness industry. Today's consumers are more proactive and discerning than ever, seeking preventive health solutions, personalized nutrition, and convenient formats like gummies and functional foods. The demand for products supporting energy, gut health, cognitive function, and longevity is exploding.

Within this landscape, the functional foods market is a key battleground. Protein-packed snacks, driven by fitness trends and the "GLP-1 lifestyle," are in high demand, as are products rich in fiber for digestive health. Rise Wellness, with its Protein Pop and clean-label bars, is positioned squarely in the center of these trends. Likewise, Hiya's focus on clean, subscription-based children's health taps into parental demand for trusted, convenient solutions for family wellness.

Meanwhile, the direct-selling industry itself is undergoing a profound transformation. The global market, valued at over $237 billion in 2025, is increasingly reliant on digital transformation, social commerce, and mobile-first platforms to compete. While USANA's core business operates within this space against heavyweights like Amway and Herbalife, its omnichannel strategy serves as a crucial hedge, diversifying its revenue streams and reducing its dependence on the challenging task of customer acquisition in the direct-sales channel.

As the August 4th release date approaches, the market will be looking for clear evidence that USANA's multi-engine approach is firing on all cylinders. The Q2 numbers and subsequent management commentary will provide the first substantive glimpse into whether the company's bold bet on diversification can successfully chart a new course for growth in the competitive future of commerce.

Topics & Related

Sector:
CPG & FMCG
Direct-to-Consumer
Event:
Quarterly Earnings
Metric:
EPS
Revenue

📝 This article is still being updated

Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.

Contribute Your Expertise →
UAID: 42956